Compared to matched non-cancerous tissues, the expression of PBRM1 is significantly decreased in breast cancer tissues, and its low expression is associated with poor clinical outcomes in breast cancer patients, further indicating its tumor suppressor function [54]. Here, PBRM1 is linked to breast cancer.